Back
Givaudan SA Vs. Charles River Laboratories International Industry Stock Comparison
Buy
85
GVDNY
Givaudan SA
Last Price:
$99.17
Seasonality Move:
4.12%
Buy
52
CRL
Charles River Laboratories International
Last Price:
$134.88
Seasonality Move:
6.13%
Buy
85
Givaudan SA (GVDNY)
is a Buy
Is Givaudan SA a Buy, Sell or Hold?
-
The current Givaudan SA [GVDNY] share price is $99.49. The Score for GVDNY is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
-
GVDNY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
52
Charles River Laboratories International (CRL)
is a Buy
Is Charles River Laboratories International a Buy, Sell or Hold?
-
The current Charles River Laboratories International [CRL] share price is $143.53. The Score for CRL is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
CRL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GVDNY Stock Price Chart
What is Givaudan SA's stock price today?
-
The Givaudan SA share price today is $99.49Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GVDNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRL Stock Price Chart
What is Charles River Laboratories International's stock price today?
-
The Charles River Laboratories International share price today is $143.53The current trend is moderately bullish and CRL is experiencing buying pressure, which is a positive indicator for future bullish movement.
GVDNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.79 | Buy |
| Relative Strength Index (14 RSI): | 65.8 | Buy |
| Chaikin Money Flow: | 8994 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (92.81 - 97.75) | Buy |
| Bollinger Bands (100): | (85.52 - 93.64) | Buy |
CRL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.89 | Buy |
| Relative Strength Index (14 RSI): | 61.23 | Buy |
| Chaikin Money Flow: | 796995 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (109.12 - 138.42) | Buy |
| Bollinger Bands (100): | (129.12 - 178.54) | Sell |
GVDNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 96.75 | Buy |
| 20-day SMA: | 96.04 | Buy |
| 50-day SMA: | 91.87 | Buy |
| 200-day SMA: | 93.42 | Buy |
| 8-day EMA: | 97.43 | Buy |
| 20-day EMA: | 95.81 | Buy |
| 50-day EMA: | 93.06 | Buy |
| 200-day EMA: | 91.1 | Buy |
CRL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 141.2 | Buy |
| 20-day SMA: | 128.43 | Buy |
| 50-day SMA: | 137.1 | Buy |
| 200-day SMA: | 176.04 | Sell |
| 8-day EMA: | 139.37 | Buy |
| 20-day EMA: | 130.91 | Buy |
| 50-day EMA: | 106.77 | Buy |
| 200-day EMA: | 45.71 | Buy |
Givaudan SA Earnings Growth & GVDNY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Charles River Laboratories International Earnings Growth & CRL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.60 per share, and an increase next year of $0.69 per share.
Givaudan SA Technical Analysis
| May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Charles River Laboratories International Technical Analysis
| May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||